Advanced glycation end product concentrations in follicular fluid of women undergoing IVF/ICSI with a GnRH agonist protocol
Reproductive BioMedicine Online Oct 02, 2017
Yao Q, et al. - The objectives of this study are to investigate whether the accumulation of advanced glycation end products (AGE) in follicular fluid influences ovarian responsiveness and embryo quality amid IVF/intracytoplasmic sperm injection (IVF/ICSI) with a gonadotrophin-releasing hormone (GnRH) agonist protocol. The outcomes propose that ovarian responsiveness and embryo quality are associated with intraovarian exposure to AGE.
- Total 127 women who underwent IVF/ICSI in GnRH agonist cycles were enrolled in this study.
- In this study, they measured the levels of AGE in follicular fluid in selected participants.
- They also measured the plasma hormones in this study.
- By utilizing standard approaches, embryos were graded.
- There was an inverse relationship between follicular fluid AGE concentration and number of oocytes retrieved, number of fertilized oocytes, number of high-quality embryos, fertilization rate and high-quality embryo rate, adjusted for potential confounders.
- AGE concentration in follicular fluid was significantly higher in women with an ovarian response below the target (<7 oocytes) compared with those reaching the target (7-15 oocytes) or above the target (>15 oocytes).
- The cut-off value of 15.3 μg/ml for follicular fluid AGE exhibited 84.6% sensitivity and 55.5% specificity in assessing the response to ovarian stimulation as below the target.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries